Abstract
The hypothesis that abnormal fibronectin metabolism in Crohn's disease could be an important mechanism leading to stricture formation or postoperative infection was tested in three related studies. (1) Lower concentrations of plasma fibronectin (p less than 0.05) were found in 20 patients with small and large bowel Crohn's disease (mean 0.24 g/l) compared with 13 patients with more limited disease confined to only small or only large bowel (mean 0.27 g/l) or 20 healthy controls (mean 0.29 g/l). (2) In 25 patients followed for 10 days after operation for Crohn's disease, there was a significant fall in fibronectin concentrations of 43% (p less than 0.01, Wilcoxon's rank-sum test). This fall was maximal on the second postoperative day and was more marked in patients undergoing more major operative procedures. (3) The predictive value of plasma fibronectin for subsequent stricture formation or progression was studied for one year; during which 10 patients developed strictures requiring operative treatment. Higher plasma fibronectin concentrations were related to stricture formation, although there was not a complete, predictive relationship. In this study we found that plasma fibronectin concentrations were low in patients with extensive or severe Crohn's disease, fall after operation and may be related to the risk of stricture formation. This relationship is unlikely to be of clinical value, although it shows the potential significance of fibronectin in the pathogenesis of strictures.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alitalo K., Hovi T., Vaheri A. Fibronectin is produced by human macrophages. J Exp Med. 1980 Mar 1;151(3):602–613. doi: 10.1084/jem.151.3.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ambrose N. S., Alexander-Williams J., Keighley M. R. Audit of sepsis in operations for inflammatory bowel disease. Dis Colon Rectum. 1984 Sep;27(9):602–604. doi: 10.1007/BF02553851. [DOI] [PubMed] [Google Scholar]
- Andre C., Descos L., Landais P., Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut. 1981 Jul;22(7):571–574. doi: 10.1136/gut.22.7.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chadwick S. J., Mowbray J. F., Dudley H. A. Plasma fibronectin and complement in surgical patients. Br J Surg. 1984 Sep;71(9):718–720. doi: 10.1002/bjs.1800710926. [DOI] [PubMed] [Google Scholar]
- Chadwick S. J., Sim A. J., Dudley H. A. Changes in plasma fibronectin during acute nutritional deprivation in healthy human subjects. Br J Nutr. 1986 Jan;55(1):7–12. doi: 10.1079/bjn19860004. [DOI] [PubMed] [Google Scholar]
- Gauperaa T., Giercksky K. E., Revhaug A., Rekvig O. P. Fibronectin, complement and immunoglobulins in serum after surgery. Br J Surg. 1985 Jan;72(1):59–62. doi: 10.1002/bjs.1800720123. [DOI] [PubMed] [Google Scholar]
- Hadjis N. S., Griffin S., Blumgart L. H., Knox P. Outcome of surgery for obstructive jaundice is not associated with reduced levels of plasma fibronectin. Clin Sci (Lond) 1986 Jan;70(1):73–79. doi: 10.1042/cs0700073. [DOI] [PubMed] [Google Scholar]
- Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
- Mosesson M. W., Amrani D. L. The structure and biologic activities of plasma fibronectin. Blood. 1980 Aug;56(2):145–158. [PubMed] [Google Scholar]
- Reese A. C., Doran J. E., Callaway B. D., Mansberger A. R. Sequestration of fibronectin at the site of an injury. Adv Shock Res. 1982;8:119–127. [PubMed] [Google Scholar]
- Robbins A. B., Doran J. E., Reese A. C., Mansberger A. R., Jr Cold insoluble globulin levels in operative trauma: serum depletion, wound sequestration, and biological activity: an experimental and clinical study. Am Surg. 1980 Dec;46(12):663–672. [PubMed] [Google Scholar]
- Rubli E., Büssard S., Frei E., Lundsgaard-Hansen P., Pappova E. Plasma fibronectin and associated variables in surgical intensive care patients. Ann Surg. 1983 Mar;197(3):310–317. doi: 10.1097/00000658-198303000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruoslahti E., Engvall E., Hayman E. G. Fibronectin: current concepts of its structure and functions. Coll Relat Res. 1981;1(1):95–128. doi: 10.1016/s0174-173x(80)80011-2. [DOI] [PubMed] [Google Scholar]
- Saba T. M., Blumenstock F. A., Scovill W. A., Bernard H. Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science. 1978 Aug 18;201(4356):622–624. doi: 10.1126/science.675246. [DOI] [PubMed] [Google Scholar]
- Saba T. M., Jaffe E. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med. 1980 Apr;68(4):577–594. doi: 10.1016/0002-9343(80)90310-1. [DOI] [PubMed] [Google Scholar]
- Saba T. M. Prevention of liver reticuloendothelial systemic host defense failure after surgery by intravenous opsonic glycoprotein therapy. Ann Surg. 1978 Aug;188(2):142–152. doi: 10.1097/00000658-197808000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scott D. L., Bedford P. A., Walton K. W. The preparation of plasma fibronectin antigen and antiserum. J Immunol Methods. 1981;43(1):29–33. doi: 10.1016/0022-1759(81)90033-8. [DOI] [PubMed] [Google Scholar]
- Scott D. L., Farr M., Crockson A. P., Walton K. W. Synovial fluid and plasma fibronectin levels in rheumatoid arthritis. Clin Sci (Lond) 1982 Jan;62(1):71–76. doi: 10.1042/cs0620071. [DOI] [PubMed] [Google Scholar]
- Scott R. L., Sohmer P. R., MacDonald M. G. The effect of starvation and repletion on plasma fibronectin in man. JAMA. 1982 Oct 22;248(16):2025–2027. [PubMed] [Google Scholar]
- Sherman L. A., Lee J. Fibronectin: blood turnover in normal animals and during intravascular coagulation. Blood. 1982 Sep;60(3):558–563. [PubMed] [Google Scholar]
- Stathakis N. E., Mosesson M. W. Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J Clin Invest. 1977 Oct;60(4):855–865. doi: 10.1172/JCI108840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TRUELOVE S. C., RICHARDS W. C. Biopsy studies in ulcerative colitis. Br Med J. 1956 Jun 9;1(4979):1315–1318. doi: 10.1136/bmj.1.4979.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamada K. M., Olden K. Fibronectins--adhesive glycoproteins of cell surface and blood. Nature. 1978 Sep 21;275(5677):179–184. doi: 10.1038/275179a0. [DOI] [PubMed] [Google Scholar]